Atea Pharmaceuticals Inc. (AVIR)
Atea Pharmaceuticals Statistics
Share Statistics
Atea Pharmaceuticals has 84.46M shares outstanding. The number of shares has increased by 0.35% in one year.
| Shares Outstanding | 84.46M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 73.98M |
| Failed to Deliver (FTD) Shares | 4.00K |
| FTD / Avg. Volume | 1.07% |
Short Selling Information
The latest short interest is 3.18M, so 3.77% of the outstanding shares have been sold short.
| Short Interest | 3.18M |
| Short % of Shares Out | 3.77% |
| Short % of Float | 4.3% |
| Short Ratio (days to cover) | 11.86 |
Valuation Ratios
The PE ratio is -1.87 and the forward PE ratio is -2.18.
| PE Ratio | -1.87 |
| Forward PE | -2.18 |
| PS Ratio | 0 |
| Forward PS | 34 |
| PB Ratio | 0.46 |
| P/FCF Ratio | -2.98 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Atea Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.24, with a Debt / Equity ratio of 0.
| Current Ratio | 18.24 |
| Quick Ratio | 18.24 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.43 |
| Cash Flow / Debt | -35.55 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.24% and return on capital (ROIC) is -29.66%.
| Return on Equity (ROE) | -0.24% |
| Return on Assets (ROA) | -0.23% |
| Return on Capital (ROIC) | -29.66% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.81M |
| Employee Count | 75 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 1.02M |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -19.59% in the last 52 weeks. The beta is 0.17, so Atea Pharmaceuticals 's price volatility has been higher than the market average.
| Beta | 0.17 |
| 52-Week Price Change | -19.59% |
| 50-Day Moving Average | 3.23 |
| 200-Day Moving Average | 3.53 |
| Relative Strength Index (RSI) | 44.39 |
| Average Volume (20 Days) | 374.07K |
Income Statement
| Revenue | n/a |
| Gross Profit | -70.09M |
| Operating Income | -164.16M |
| Net Income | -135.96M |
| EBITDA | -119.59M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.63 |
Balance Sheet
The company has 143.82M in cash and 2.40M in debt, giving a net cash position of 141.42M.
| Cash & Cash Equivalents | 143.82M |
| Total Debt | 2.40M |
| Net Cash | 141.42M |
| Retained Earnings | -195.84M |
| Total Assets | 490.96M |
| Working Capital | 461.72M |
Cash Flow
In the last 12 months, operating cash flow was -85.39M and capital expenditures 0, giving a free cash flow of -85.39M.
| Operating Cash Flow | -85.39M |
| Capital Expenditures | 0 |
| Free Cash Flow | -85.39M |
| FCF Per Share | -1.02 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -51.58% |
| FCF Yield | -32% |
Analyst Forecast
The average price target for AVIR is $6.88, which is 117.7% higher than the current price. The consensus rating is "Hold".
| Price Target | $6.88 |
| Price Target Difference | 117.7% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 3.83 |
| Piotroski F-Score | 1 |